首页> 美国卫生研究院文献>ACS Medicinal Chemistry Letters >Targeting Tumor Associated Carbonic Anhydrases IXand XII: Highly Isozyme Selective Coumarin and Psoralen Inhibitors
【2h】

Targeting Tumor Associated Carbonic Anhydrases IXand XII: Highly Isozyme Selective Coumarin and Psoralen Inhibitors

机译:靶向肿瘤相关的碳酸酐酶IX和XII:高度同工酶选择性香豆素和补骨脂素抑制剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A small library of psoralen carboxylic acids and their corresponding benzenesulfonamide derivatives were designed and synthesized to evaluate their activity and selectivity toward tumor associated human carbonic anhydrase (hCA) isoforms IX and XII. Both psoralen acids and sulfonamides exhibited potent inhibition of IX and XII isozymes in the nanomolar concentration range. However, psoralen acids resulted as the most selective in comparison with the corresponding benzenesulfonamide derivatives. Our data indicate that the psoralen scaffold is a promising starting point for the design of highly selective tumor associated hCA inhibitors.
机译:设计并合成了一个小型补骨脂素羧酸库及其相应的苯磺酰胺衍生物,以评估其对肿瘤相关的人类碳酸酐酶(hCA)亚型IX和XII的活性和选择性。补骨脂酸和磺酰胺在纳摩尔浓度范围内均表现出对IX和XII同功酶的有效抑制作用。然而,与相应的苯磺酰胺衍生物相比,补骨脂酸的选择性最高。我们的数据表明,补骨脂素支架是设计高选择性肿瘤相关hCA抑制剂的有希望的起点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号